Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Clinicopathological study of 9 cases of prostate cancer involving the rectal wall.

Tang T, Yang Z, Zhang D, Qu J, Liu G, Zhang S.

Diagn Pathol. 2017 Jan 17;12(1):8. doi: 10.1186/s13000-017-0599-2.

2.

Metastatic rectal adenocarcinoma in the mandibular gingiva: a case report.

Watanabe M, Tada M, Satomi T, Chikazu D, Mizumoto M, Sakurai H.

World J Surg Oncol. 2016 Jul 29;14(1):199. doi: 10.1186/s12957-016-0958-6.

3.

SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.

Lundberg IV, Edin S, Eklöf V, Öberg Å, Palmqvist R, Wikberg ML.

BMC Cancer. 2016 Jul 13;16:471. doi: 10.1186/s12885-016-2509-5.

4.

Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation.

Zhang Y, Wang H, Bi C, Xiao Y, Liu Z.

Oncotarget. 2016 Aug 23;7(34):54973-54982. doi: 10.18632/oncotarget.10362.

5.

Identifying cancer origin using circulating tumor cells.

Lu SH, Tsai WS, Chang YH, Chou TY, Pang ST, Lin PH, Tsai CM, Chang YC.

Cancer Biol Ther. 2016 Apr 2;17(4):430-8. doi: 10.1080/15384047.2016.1141839.

6.

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF.

N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.

7.

Metastatic mucinous adenocarcinoma of the distal common bile duct, from transverse colon cancer presenting as obstructive jaundice.

Lee DH, Ahn YJ, Shin R, Lee HW.

Korean J Hepatobiliary Pancreat Surg. 2015 Aug;19(3):125-8. doi: 10.14701/kjhbps.2015.19.3.125. Epub 2015 Aug 28.

8.

Reactivation of CDX2 in Gastric Cancer as Mark for Gene Silencing Memory.

Kameoka Y, Kitazawa R, Ariasu K, Tachibana R, Mizuno Y, Haraguchi R, Kitazawa S.

Acta Histochem Cytochem. 2015 Aug 27;48(4):115-24. doi: 10.1267/ahc.15014. Epub 2015 Aug 20.

9.

SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.

Li Z, Yuan J, Wei L, Zhou L, Mei K, Yue J, Gao H, Zhang M, Jia L, Kang Q, Huang X, Cao D.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7072-82. eCollection 2015 Jun 1.

10.

Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Bae JM, Lee TH, Cho NY, Kim TY, Kang GH.

World J Gastroenterol. 2015 Feb 7;21(5):1457-67. doi: 10.3748/wjg.v21.i5.1457.

11.

Cdx1 and Cdx2 function as tumor suppressors.

Hryniuk A, Grainger S, Savory JG, Lohnes D.

J Biol Chem. 2014 Nov 28;289(48):33343-54. doi: 10.1074/jbc.M114.583823. Epub 2014 Oct 15.

12.

Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.

Xiao W, Hong H, Awadallah A, Zhou L, Xin W.

PLoS One. 2014 Jan 29;9(1):e86853. doi: 10.1371/journal.pone.0086853. eCollection 2014 Jan 29.

13.
14.

Colorectal carcinoma: Pathologic aspects.

Fleming M, Ravula S, Tatishchev SF, Wang HL.

J Gastrointest Oncol. 2012 Sep;3(3):153-73. doi: 10.3978/j.issn.2078-6891.2012.030.

15.

Caudal homeobox protein Cdx-2 cooperates with Wnt pathway to regulate claudin-1 expression in colon cancer cells.

Bhat AA, Sharma A, Pope J, Krishnan M, Washington MK, Singh AB, Dhawan P.

PLoS One. 2012;7(6):e37174. doi: 10.1371/journal.pone.0037174. Epub 2012 Jun 15.

16.

siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells.

Wang XT, Xie YB, Xiao Q.

World J Gastroenterol. 2012 Apr 28;18(16):1903-14. doi: 10.3748/wjg.v18.i16.1903.

18.

CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Saad RS, Ghorab Z, Khalifa MA, Xu M.

World J Gastrointest Surg. 2011 Nov 27;3(11):159-66. doi: 10.4240/wjgs.v3.i11.159.

19.

Molecular mechanisms of Barrett's esophagus.

Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X.

Dig Dis Sci. 2011 Dec;56(12):3405-20. doi: 10.1007/s10620-011-1885-6. Epub 2011 Oct 8. Review.

20.

Pathophysiology and biology of peritoneal carcinomatosis.

Kusamura S, Baratti D, Zaffaroni N, Villa R, Laterza B, Balestra MR, Deraco M.

World J Gastrointest Oncol. 2010 Jan 15;2(1):12-8. doi: 10.4251/wjgo.v2.i1.12.

Supplemental Content

Support Center